Endo International Ordinary Shares reported $226.56M in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aerie Pharmaceuticals AERI:US $ -16.59M 15.45M
Amarin AMRN:US $ -36.84M 9.31M
Bristol Myers Squibb BMY:US $ 5780M 8M
Eli Lilly And LLY:US $ 1999.4M 1006.2M
Endo International Ordinary Shares ENDP:US $ 226.56M 52.35M
Heron Therapeutics HRTX:US $ -62.2M 9.46M
Hikma Pharmaceutical HIK:LN 349M 19M
Horizon Pharma HZNP:US $ 244.43M 47.12M
JAZZ PHA JAZZ:US $ 282.55M 15.29M
Lannett LCI:US $ -12.48M 3.96M
Novartis NOVN:VX SF 4660M 108M
Pacira Pharmaceuticals PCRX:US $ 34.04M 7.72M
Perrigo Ordinary Shares PRGO:US $ 92.6M 43.6M
Pfizer PFE:US $ 12921M 1739M
Phibro Animal Health PAHC:US $ 27.64M 2.66M
Revance Therapeutics RVNC:US $ -56.84M 0.66M
Supernus Pharmaceuticals SUPN:US $ 31.99M 8.66M
Takeda 4502:JP Y 308798M 158143M
Teva Pharmaceutical TEVA:IT 1.09B 20M
Xeris Pharmaceuticals Inc XERS:US $ -16042000 29.13M
Zoetis ZTS:US $ 854M 54M